Skye Bioscience, Inc. Quarterly Operating Income (Loss) in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Skye Bioscience, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2012 to Q3 2024.
  • Skye Bioscience, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.97M, a 79.9% increase year-over-year.
  • Skye Bioscience, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$23.6M, a 40.9% increase year-over-year.
  • Skye Bioscience, Inc. annual Operating Income (Loss) for 2023 was -$34.7M, a 89.7% decline from 2022.
  • Skye Bioscience, Inc. annual Operating Income (Loss) for 2022 was -$18.3M, a 133% decline from 2021.
  • Skye Bioscience, Inc. annual Operating Income (Loss) for 2021 was -$7.85M, a 24.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$23.6M -$4.97M +$19.7M +79.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$43.3M -$8.41M -$5.56M -196% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$37.8M -$6.15M -$3.05M -98.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$34.7M -$4.09M +$5.2M +56% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-22
Q3 2023 -$39.9M -$24.7M -$21.8M -745% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$18.1M -$2.84M +$375K +11.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$18.5M -$3.1M -$212K -7.35% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$18.3M -$9.28M -$6.82M -277% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-22
Q3 2022 -$11.5M -$2.92M -$1.1M -60.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$10.4M -$3.22M -$1.39M -75.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$9M -$2.89M -$1.15M -66.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$7.85M -$2.46M -$1.14M -86.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$6.7M -$1.82M -$281K -18.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$6.42M -$1.83M -$609K -49.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$5.82M -$1.74M +$474K +21.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$6.29M -$1.32M +$525K +28.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 -$6.81M -$1.54M -$35.1K -2.34% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$6.78M -$1.22M +$550K +31.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$7.33M -$2.21M -$696K -45.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$6.63M -$1.84M -$528K -40.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-02
Q3 2019 -$6.1M -$1.5M -$457K -43.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$5.65M -$1.77M -$691K -63.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$4.96M -$1.52M -$264K -21.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$4.69M -$1.32M -$329K -33.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-23
Q3 2018 -$4.36M -$1.05M -$284K -37.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$4.08M -$1.08M -$349K -47.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$3.73M -$1.25M +$129K +9.33% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$3.86M -$987K -$74.5K -8.16% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 -$3.78M -$762K +$94.5K +11% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$3.88M -$731K +$751K +50.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$4.63M -$1.38M -$160K -13.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$4.47M -$912K +$242K +21% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-19
Q3 2016 -$4.71M -$856K +$40.1K +4.48% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$4.75M -$1.48M -$125K -9.25% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$4.63M -$1.22M -$311K -34.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$4.32M -$1.15M +$547K +32.1% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-10
Q3 2015 -$4.86M -$896K -$38.7K -4.51% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$4.83M -$1.36M -$1.21M -849% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 -$3.61M -$910K -$880K -2923% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$2.73M -$1.7M -$471K -38.3% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-21
Q3 2014 -$2.26M -$858K -$828K -2749% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$1.43M -$143K -$144K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$1.29M -$30.1K -$33.7K -933% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 -$1.26M -$1.23M -$1.22M -19758% Nov 1, 2013 Jan 31, 2014 10-Q 2014-03-17
Q3 2013 -$31.9K -$30.1K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $744* +$837 May 1, 2013 Jul 31, 2013 10-Q 2014-09-15
Q1 2013 $3.61K +$4.16K Jan 31, 2013 Apr 30, 2013 10-Q 2014-06-05
Q4 2012 -$6.19K Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q2 2012 -$93* May 1, 2012 Jul 31, 2012 10-Q 2013-09-16
Q1 2012 -$550* Jan 31, 2012 Apr 30, 2012 10-Q 2013-06-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.